title: Estrogen treatment effects on cognition, memory and mood in male-to-female transsexuals.
abstract: Gonadal hormones, particularly estrogens, have been suggested to influence memory and cognitive tasks that show sex differences. Previously, we reported that male-to-female (M-F) transsexuals undergoing estrogen treatment for sex re-assignment scored higher on verbal Paired Associate Learning (PAL) than a transsexual control group awaiting estrogen treatment. The present study used a more robust design to examine further associations between estrogen and cognition. We assessed additional aspects of memory, including visual, spatial, object and location memory, other cognitive abilities that show reliable sex differences, including verbal and visual-spatial abilities, and mood variables that could mediate associations between estrogen and cognition. In addition to comparing groups of individuals on and off estrogen, we used two repeated measures designs (AB and BA). The AB group was tested prior to hormone treatment and then again after treatment had begun; the BA group was tested while on estrogen treatment and then again when hormones had been withdrawn prior to surgery. Few changes in memory or cognition were observed, and changes that were observed were not consistent across study designs. The lack of significant effects did not relate to mood changes or to the sexual orientation of participants. These findings suggest that estrogen treatment associated with sex change for M-F transsexuals has little or no influence on sex-typed aspects of cognition or memory.
authors.affiliation: Department of Psychology, City University, London, UK.
authors.forename: Clare
authors.initials: C
authors.lastname: Miles
authors.forename: Richard
authors.initials: R
authors.lastname: Green
authors.forename: Melissa
authors.initials: M
authors.lastname: Hines
mesh_terms: D000328:Adult; D000339:Affect / Q000187:drug effects*; D003071:Cognition / Q000187:drug effects*; D017373:Cyproterone Acetate / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D008568:Memory / Q000187:drug effects*; D014189:Transsexualism / Q000188:drug therapy* / Q000523:psychology*
chemical_list: D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; D017258:Medroxyprogesterone Acetate